K. Reiss et al., INHIBITION OF TUMOR-GROWTH BY A DOMINANT-NEGATIVE MUTANT OF THE INSULIN-LIKE-GROWTH-FACTOR-I RECEPTOR WITH A BYSTANDER EFFECT, Clinical cancer research, 4(11), 1998, pp. 2647-2655
The insulin-like growth factor I receptor is known to play a major rol
e in transformation and apoptosis. The dominant negative mutant of the
insulin-like growth factor I receptor, designated 486/STOP, causes ma
ssive apoptosis of tumor cells and inhibition of tumor growth and meta
stases. We now show that: (a) the stable expression of 486/STOP inhibi
ts transformation (colony formation in soft agar) and/or tumor growth
in nude mice of five different types of human tumor cell lines; and (b
) more importantly, it has a bystander effect, inhibiting the growth o
f wild-type tumor cells when cells expressing 486/STOP are coinjected
with wild-type tumor cells. These findings suggest that it is not nece
ssary to infect all tumor cells with 486/STOP to inhibit tumor growth,
and they also open the possibility of using the product of 486/STOP d
irectly against tumor cells.